Deals Provide Map On Lupin’s AimTo Triple Sales To $5 Billion By 2018
This article was originally published in PharmAsia News
Executive Summary
Lupin Managing Director Nilesh Gupta is calm about achieving $5 billion sales by 2018, or maybe the year after – a target that is roughly three times of its present size. He gets comfort from what he says is a well-designed strategy, parts of which he shared in a conversation with PharmAsia News.